Löddeköpinge, Sweden

Ann-Kristin Mossberg

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Hamlet Pharma Ab. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann-Kristin Mossberg. Retrieved from https://idiyas.com/inventor/ann-kristin-mossberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Biography of Ann-Kristin Mossberg

Introduction

Ann-Kristin Mossberg is an accomplished inventor based in Loddekopinge, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of biologically active complexes.

Latest Patents

Mossberg holds three patents, with her latest focusing on a biologically active complex and its preparation. This complex comprises either a polypeptide with a sequence variant of a naturally occurring protein or a peptide of up to 50 amino acids. The invention demonstrates a novel mode of action, which opens up opportunities for the development of further active agents and screening methods.

Career Highlights

Mossberg is currently associated with Hamlet Pharma AB, where she continues to innovate and contribute to the field. Her work has been pivotal in advancing the understanding of biologically active compounds.

Collaborations

Throughout her career, Mossberg has collaborated with notable colleagues, including Catharina Svanborg and Kenneth Hun Mok. These partnerships have enhanced her research and development efforts.

Conclusion

Ann-Kristin Mossberg's work exemplifies the impact of innovative thinking in biotechnology. Her patents and collaborations reflect her commitment to advancing scientific knowledge and developing new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…